8B6X

NMR assignment and structure of a peptide derived from the membrane proximal external region of HIV-1 gp41 in DPC micelles


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: target function 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope.

Torralba, J.de la Arada, I.Partida-Hanon, A.Rujas, E.Arribas, M.Insausti, S.Valotteau, C.Valle, J.Andreu, D.Caaveiro, J.M.M.Jimenez, M.A.Apellaniz, B.Redondo-Morata, L.Nieva, J.L.

(2022) Commun Biol 5: 1265-1265

  • DOI: https://doi.org/10.1038/s42003-022-04219-6
  • Primary Citation of Related Structures:  
    8B6X, 8B6Y

  • PubMed Abstract: 

    Antibodies against the carboxy-terminal section of the membrane-proximal external region (C-MPER) of the HIV-1 envelope glycoprotein (Env) are considered as nearly pan-neutralizing. Development of vaccines capable of producing analogous broadly neutralizing antibodies requires deep understanding of the mechanism that underlies C-MPER recognition in membranes. Here, we use the archetypic 10E8 antibody and a variety of biophysical techniques including single-molecule approaches to study the molecular recognition of C-MPER in membrane mimetics. In contrast to the assumption that an interfacial MPER helix embodies the entire C-MPER epitope recognized by 10E8, our data indicate that transmembrane domain (TMD) residues contribute to binding affinity and specificity. Moreover, anchoring to membrane the helical C-MPER epitope through the TMD augments antibody binding affinity and relieves the effects exerted by the interfacial MPER helix on the mechanical stability of the lipid bilayer. These observations support that addition of TMD residues may result in more efficient and stable anti-MPER vaccines.


  • Organizational Affiliation

    Instituto Biofisika (CSIC-UPV/EHU), University of the Basque Country (UPV/EHU), PO Box 644, 48080, Bilbao, Spain.


Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Envelope glycoprotein gp16025Human immunodeficiency virus 1Mutation(s): 0 
Membrane Entity: Yes 
UniProt
Find proteins for A0A2P1GRC5 (Human immunodeficiency virus 1)
Explore A0A2P1GRC5 
Go to UniProtKB:  A0A2P1GRC5
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A2P1GRC5
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 100 
  • Conformers Submitted: 20 
  • Selection Criteria: target function 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Agencia Estatal de Investigacion (AEI)SpainPID2020-112821GB-I00
Agencia Estatal de Investigacion (AEI)SpainPID2021-12601OB-I00

Revision History  (Full details and data files)

  • Version 1.0: 2022-11-30
    Type: Initial release